Literature DB >> 9540288

Cancer metastasis: biological and clinical aspects.

M J Duffy1.   

Abstract

The main cause of morbidity and mortality in cancer is the formation of distant metastases. While alterations in c-oncogenes, tumour suppressor genes and DNA repair enzymes are the key molecules involved in carcinogenesis, increased expression of proteases, motility factors and altered expression of adhesion molecules are causally involved in metastasis. The proteases mediating metastasis include urokinase plasminogen activator, cathepsin B, D and L and various matrix metalloproteinases. Certain proteases involved in metastasis (e.g., urokinase plasminogen activator) have been shown to be strong and independent prognostic markers for a variety of cancers. Finally, molecules involved in cancer spread are potential targets for new forms of anti-metastatic therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540288     DOI: 10.1007/bf02937542

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  19 in total

1.  L-selectin-mediated lymphocyte rolling on MAdCAM-1.

Authors:  E L Berg; L M McEvoy; C Berlin; R F Bargatze; E C Butcher
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

Review 2.  The biochemistry of metastasis.

Authors:  M J Duffy
Journal:  Adv Clin Chem       Date:  1996       Impact factor: 5.394

Review 3.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

4.  Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

Authors:  M J Duffy; D Reilly; C O'Sullivan; N O'Higgins; J J Fennelly; P Andreasen
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

5.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

Review 6.  Biological and clinical significance of cathepsin D in breast cancer metastasis.

Authors:  M Garcia; N Platet; E Liaudet; V Laurent; D Derocq; J P Brouillet; H Rochefort
Journal:  Stem Cells       Date:  1996-11       Impact factor: 6.277

7.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

8.  Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.

Authors:  M J Duffy; P O'Grady; D Devaney; L O'Siorain; J J Fennelly; H J Lijnen
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

Review 9.  Proteases as prognostic markers in cancer.

Authors:  M J Duffy
Journal:  Clin Cancer Res       Date:  1996-04       Impact factor: 12.531

10.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; M Moses; W S Lane; Y Cao; E H Sage; J Folkman
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

View more
  2 in total

Review 1.  Genes that regulate metastasis and angiogenesis.

Authors:  C P Webb; G F Vande Woude
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.

Authors:  Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.